Intrinsic Value

The intrinsic value of JLK Inc (322510) under the Base Case is 393.84 KRW per share. Compared with the current market price of 3 740 KRW, the stock appears Overvalued by 89% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

Intrinsic Value
₩393.84
Overvaluation 89%
Intrinsic Value
Price ₩3 740
Alert me when JLK Inc is below its intrinsic value
Today ₩315.07 · 91.6% below the current price

JLK Inc is valued in line with its history. A premium of this size has been typical over the past 5 years.

Alternatives to JLK Inc

Fundamental Analysis

What JLK Does

Health Care

JLK Inc is a South Korean medical software company that makes artificial intelligence tools for reading medical images. Its products help doctors look at CT and MRI scans, especially in emergency care such as stroke detection, brain imaging, and related neurological conditions. The company sells software that can flag abnormal findings, support faster decisions, and help hospitals handle scans more efficiently.

Headquarters
Korea KR
IPO date
Dec 11, 2019
Read the full company overview
View Company Overview
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Continue Research

Decided on JLK? Get an email when JLK Inc reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one JLK Inc stock?

The intrinsic value for JLK Inc (322510) under the Base Case is 393.84 KRW.

Is JLK Inc stock undervalued or overvalued?

Compared with the current market price of 3 740 KRW, the stock appears Overvalued by 89% .

How reliable are our estimates? See how past valuations played out
Back to Top